[1]
M. Habuka, S. Otsuka, K. Satokata, A. Ogawa, and S. Yamamoto, “Urate-Lowering Effect of Dotinurad During Concomitant Sodium-Glucose Cotransporter 2 Inhibitor Therapy for Chronic Kidney Disease: A Retrospective Study”, J Clin Med Res, vol. 18, no. 11, pp. 815–822, Jan. 2026, doi: 10.14740/jocmr6733.